Alexander Maxwell
Latest Articles
Breaking Down Synergy's Earnings, Is There Hope On The Horizon?
Titan Pharmaceuticals: Spiraling Towards The End?
Synergy Pharmaceuticals: Is The End Near?
Merrimack Pharmaceuticals: Where Do We Go From Here?
Adamis Pharmaceuticals: Where Do We Go From Here?
Should Valeant Shareholders Be Content With The Firesale Beginning?
ITT Educational Services At The End Of The Road
Why Recent Fanapt Ruling Is Important To Vanda
Antares Pharmaceuticals: The Stock To Buy On EpiPen Issues
Momenta Has Momentum After Recent Patent Decision
Stemcell Merger: Why It Happened
Hain: Buy After Pullback
Breaking Down FORM Holdings' Earnings
Sarepta: The Competition Is At The Gate
Is Mannkind Near The End?
Amarin: Dilution May Be A Bump In The Road
BioDelivery Earnings: Here Is What To Watch
How To Trade Durect Heading Into Remoxy Decision Date
Should Juno Be A Warning To All CAR-T Researchers?
What Should Ariad Shareholders Watch For Heading Towards The End Of The Year?
What Arena's Recent FDA Approval Means For The Future
What Investors Should Know About The Opioid Epidemic
Gilead: All Eyes On FDA This Week
Williams Companies: The Sky Is Not Falling
Adamis Pharmaceuticals: The CRL Post-Mortem
Ionis Shareholders Cannot Catch A Break
Is Eteplirsen About To Be Approved?
Sarepta Therapeutics: How Should Investors View News In This Battleground Stock?
Watch This Stock Heading Into PDUFA Decision Date
2 FDA Decisions To Watch In June
Next Steps For Intercept Pharmaceuticals Following FDA Approval
Titan Pharmaceuticals: What To Look For After Probuphine Approval